Chronic myeloid leukemia (CML) is a clonal disease distinguished by BCR/ABL, a constitutively activated tyrosine kinase created from the reciprocal translocation between chromosomes 9 and 22. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.